| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.051 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |